Smith and Nephew sells US gloves business
This article was originally published in Clinica
Smith & Nephew (UK) is to sell its US-based gloves business, Perry, to Ansell for £31 million ($50 million). The gloves business, which reported profits of £3.4 million on sales of £41 million in 1994, has been a potential candidate for disposal as Smith & Nephew focuses on its core businesses. "In an increasingly competitive market, surgical gloves now are not readily sold alongside our product range," comments Smith & Nephew chief executive John Robinson.
You may also be interested in...
A reagent in a batch of COVID-19 tests shipped by the US Centers for Disease Control and Prevention to state laboratories “wasn’t performing consistently,” a top CDC official says, so the agency is reformulating it – slowing down the labs’ ability to use the diagnostic, which yielded inconsistent results when quality-tested. But waiting in the wings are commercial coronavirus test kits being developed by Qiagen and Cepheid; both firms say they’ll submit the kits to the FDA for emergency-use approval.
OIG will focus on successful drugs that have been repurposed as orphans, noting nine of the 10 top selling drugs have both orphan and non-orphan indications.
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.